China Computed Tomography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The China Computed Tomography (CT) Market Report is Segmented by Type (Low Slice, Medium Slice, and High Slice), Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications), and End User (Hospitals, Diagnostic Centers, and Other End Users). The Report Offers the Value (USD) for all the Above Segments.

China Computed Tomography Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
China Computed Tomography Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 1.34 Billion
Market Size (2029) USD 1.79 Billion
CAGR (2024 - 2029) 5.98 %
Market Concentration Medium

Major Players

China Computed Tomography Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

China Computed Tomography Market Analysis

The China Computed Tomography Market size is estimated at USD 1.34 billion in 2024, and is expected to reach USD 1.79 billion by 2029, growing at a CAGR of 5.98% during the forecast period (2024-2029).

Factors such as the growing burden of chronic diseases and technological advancements in computed tomography are expected to drive the market during the forecast period. For instance, according to a study published in the Chinese Medical Journal in March 2022, there were around 4,820,000 cancer cases and 3,210,000 cancer deaths in China in 2022. In China, lung cancer is the most frequent type of cancer. Thus, the growing burden of cancer is expected to boost the demand for effective diagnosis devices, which is likely to contribute to market growth.

China offers many opportunities to key players in the market. Therefore, many foreign players are trying to establish their presence in the Chinese market. For instance, in February 2022, Siemens Healthineers and Universal Medical Imaging agreed to promote 5G remote imaging diagnosis for primary care in China.

Various strategic initiatives are being undertaken by the major players. These include mergers, acquisitions, collaborations, partnerships, and product launches. Similarly, the introduction of AI-powered technologies in CT scanning is expected to boost market growth. For instance, in May 2023, Royal Philips, the parent company of Philips Healthcare, introduced a cutting-edge 32/64-slice CT scanner powered by artificial intelligence (AI). This innovative scanner is designed to bolster both routine radiology studies and large-scale screening programs.

Hence, owing to these factors, the market is expected to witness significant growth in the country. However, the high cost associated with the CT scan and procedures may hamper market growth over the forecast period.

China Computed Tomography Market Trends

Hospitals are Expected to Hold a Significant Share Over the Forecast Period

Hospitals are the major end users of computed tomography and are expected to hold a significant share.

Factors such as the high frequency of dental and cardiovascular ailments, orthopedic diseases, and cancer, strategic efforts by leading companies, and huge investments in the healthcare industry are likely to drive segmental growth. Additionally, population awareness of CT imaging services is projected to increase market growth.

The country's growing burden of chronic diseases and the launch of new establishments in China further require imaging diagnosis, which is likely to boost the segment's growth. For instance, in November 2023, Guangzhou Royal Li Cancer Hospital introduced SPECT/CT equipment for the Nuclear Medicine Department. The first scan was conducted on a patient with recurring cervical cancer. Thus, the increase in the introduction of advanced CT scans is expected to increase the demand for effective diagnosis and boost segmental growth.

Strategic collaborations and partnerships in the segment propel the country's market growth. For instance, in February 2023, GE Healthcare planned to establish a fresh joint venture facilitated by its Chinese arm, which will collaborate with Sinopharm's China National Medical Device Company. GE Healthcare and Sinopharm renewed their collaboration, focusing on developing and commercializing medical equipment tailored to meet China's healthcare demands. The collaboration included establishing a clinical diagnostics laboratory for creating an integrated and patient-centric disease diagnosis, treatment, and rehabilitation for cancer patients.

Hence, with the above-mentioned factors, hospitals are expected to play a crucial role in the computed tomography market in China.

China Computed Tomography Market: Number of Breast Cancer Cases (In Million), China, 2022 – 2035

The Neurology Segment is Expected to Hold a Significant Share Over the Forecast Period

The factors propelling the segment's growth include the increase in neurological disorders, huge investments by private players in neurology devices, and product launches by market players.

Many neurological disorders share specific characteristics, and a CT scan can aid in proper diagnosis by differentiating the area of the brain affected by the disorder. The ultimate goal of a CT scan is to provide a clearer brain structure for diagnosis. In the majority of brain diseases, such as vertigo, skull fracture, cerebral infarction, Alzheimer's, and epilepsy, CT images aim to distinguish abnormalities in the structure. The growing aging population, which is more prone to neurological diseases, is expected to boost the market growth over the forecast period.

According to the data published by the China Alzheimer Report 2022, China's population of Alzheimer's patients was about 6 million, with the percentage of individuals with dementia being 5%, 11.5%, and 30% among 65-, 75-, and 85-year-olds. Epilepsy has neurological, cognitive, psychological, and social consequences. People with epilepsy have a two to four times higher risk of fatal injuries. Thus, the huge burden of neurological diseases is expected to lead to a rise in demand for effective diagnosis, propelling the demand for CT in China and boosting the segment’s growth.

Thus, all factors mentioned above are expected to boost the segment’s growth over the forecast period.

China Computed Tomography Market: Prevalence of Cancer (in Million), China, 2022-2035

China Computed Tomography Industry Overview

China's computed tomography (CT) market is semi-consolidated due to the presence of a few major players, including Canon Medical Systems Corporation, Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers. These major players hold a significant share in the market. Most players focus on bringing technologically advanced products into the market to acquire the maximum market share.

China Computed Tomography Market Leaders

  1. GE Healthcare

  2. FUJIFILM Holdings Corporation

  3. Canon Medical Systems

  4. Koninklijke Philips N.V.

  5. Siemens Healthineers

*Disclaimer: Major Players sorted in no particular order

China Computed Tomography Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

China Computed Tomography Market News

  • December 2023: GE Healthcare officially launched its first domestically produced ultra-high-end CT, the RevolutionApexTMExpert, based on the Quantum platform. The system was developed at its Beijing Imaging Equipment Manufacturing Base in Beijing E-Town.
  • March 2023: Elekta launched a cooperative venture with China National Pharmaceutical Group Co. Ltd (Sinopharm) to expand the use of radiation therapy in so-called lower-tier cities, where around 70% of the population lives.

China Computed Tomography Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population and Chronic Disease Burden
    • 4.2.2 Technological Advancements in Computed Tomography
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated With CT Scan Procedure and Equipment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Type
    • 5.1.1 Low Slice
    • 5.1.2 Medium Slice
    • 5.1.3 High Slice
  • 5.2 By Application
    • 5.2.1 Oncology
    • 5.2.2 Neurology
    • 5.2.3 Cardiovascular
    • 5.2.4 Musculoskeletal
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End Users

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems Corporation
    • 6.1.2 Fujifilm Holdings Corporation
    • 6.1.3 GE Healthcare
    • 6.1.4 Koninklijke Philips NV
    • 6.1.5 Siemens Healthineers
    • 6.1.6 Naugra Medical Lab
    • 6.1.7 Neusoft Medical Systems Co. Ltd
    • 6.1.8 Planmed Oy
    • 6.1.9 MinFound Medical Systems Co. Ltd
    • 6.1.10 Shenzhen Anke High-tech Co. Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

China Computed Tomography Industry Segmentation

As per the scope of the report, computed tomography (CT) is an imaging process that customizes special X-ray equipment to generate a sequence of exhaustive images or scans of areas inside the body.

China's computed tomography (CT) market is segmented by type, application, and end user. By type, the market is segmented into low slice, medium slice, and high slice. By application, the market is segmented into oncology, neurology, cardiovascular, musculoskeletal, and other applications. By end user, the market is segmented into hospitals, diagnostic centers, and other end users. The report offers the value (USD) for all the above segments.

By Type Low Slice
Medium Slice
High Slice
By Application Oncology
Neurology
Cardiovascular
Musculoskeletal
Other Applications
By End User Hospitals
Diagnostic Centers
Other End Users
Need A Different Region Or Segment?
Customize Now

China Computed Tomography Market Research FAQs

The China Computed Tomography Market size is expected to reach USD 1.34 billion in 2024 and grow at a CAGR of 5.98% to reach USD 1.79 billion by 2029.

In 2024, the China Computed Tomography Market size is expected to reach USD 1.34 billion.

GE Healthcare, FUJIFILM Holdings Corporation, Canon Medical Systems, Koninklijke Philips N.V. and Siemens Healthineers are the major companies operating in the China Computed Tomography Market.

In 2023, the China Computed Tomography Market size was estimated at USD 1.26 billion. The report covers the China Computed Tomography Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Computed Tomography Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

China Computed Tomography Industry Report

Statistics for the 2024 China Computed Tomography market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Computed Tomography analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

China Computed Tomography Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)